The DOI matches its Crossref record; 86 of the 93 references it cites were found in a registry or an index.
Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the pathways involved in the natural resistance of cancer cells to cytotoxic insults including radio-/chemotherapy.Explain autophagic cell death as a potent alternative tumor-suppressing mechanism.Identify the common targets in apoptosis and autophagy resistance pathways and the surrogate markers that could be used in clinical practice for proautophagic therapy.Discuss the rationale for incorporating endoplasmic reticulum stress inhibitors as adjuvant chemotherapies against apoptosis-resistant cancers. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As the suppression of autophagy to sustain the cytotoxicity of chemotherapeutic drugs is a novel strategy for cancer chemotherapy3435, HDAC10 is an emerging target for the treatment of advanced-stage neuroblastoma32.”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [35]
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Self-eating and self-killing: crosstalk between autophagy and apoptosis
Maiuri, M. C., Zalckvar, E., Kimchi, A., & Kroemer, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2239 · Cited by 3,638
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033 · cited 1×
“The autophagy story began in 1966 when De Duve and Wattiaux [ 28 ] discovered lysosomes, with the significance that autophagy is a lysosome-mediated degradation of proteins and cellular organelles [27].”
BackgroundAutophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,559
The role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R. A., & Kondo, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1692 · Cited by 1,673
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,586
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
Autophagy as a cell death and tumor suppressor mechanism
Gözüaçık, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,396
Cited by
Sorted by citations
Items 201–238 of 238
Chong, S. X., Jin, Y., Au‐Yeung, S. C. F., & To, K. K. W. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.02.002 · Cited by 5
Gymnema sylvestre Extract Restores the Autophagic Pathway in Human Glioblastoma Cells U87Mg
Rotondo, R., Castaldo, S., Oliva, M. A., & Arcella, A. (2021) · Biology · doi:10.3390/biology10090870 · Cited by 4
Effect of polygodial and its direct derivatives on the mammalian Na + /K + -ATPase activity
Garcia, D. G., Gonçalves-de-Albuquerque, C. F., da Silva, C. I., Robert Kiss, A., Dasari, R., Chandra, S., Kornienko, A., & Burth, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.031 · Cited by 3
Mechanisms of cell resistance in glioblastoma multiforme
Sarafian, V. S. (2010) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.1512009_6 · Cited by 4
D'Herde, K. G. M. A., Diez‐Fraile, A., & Lammens, T. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9293-0_2 · Cited by 4
The development of cytotoxic chemotherapeutics in the twentieth century
TEMEL, M. K. (2015) · Turkish Journal of Oncology · doi:10.5505/tjoncol.2015.1151 · Cited by 4
Zhang, H., Wen, C., Li, B., Yan, X., Xu, Y., Guo, J., Shi, H., Chang, J., Li, S., & Xiao, J. (2022) · Molecules · doi:10.3390/molecules27082428 · Cited by 3
The Role of Autophagy in Childhood Central Nervous System Tumors
Wang, Y., Xu, Y., & Zhu, C. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-01015-6 · Cited by 3
Plant-Derived Isoprenoids Mediate Regulation of mTOR Signaling in Tumor Cells
Peffley, D. M., & Hentosh, P. (2012) · Springer eBooks · doi:10.1007/978-94-007-4575-9_15 · Cited by 3
Paul-Samojedny, M., Liduk, E., Borkowska, P., Zielińska, A., Kowalczyk, M., Suchanek-Raif, R., & Kowalski, J. (2022) · Processes · doi:10.3390/pr10030441 · Cited by 2
The Role of Pyk2 Kinase in Glioblastoma Progression and Therapeutic Targeting
Kucheryavykh, L. Y., & Kucheryavykh, Y. V. (2025) · Cancers · doi:10.3390/cancers17162611 · Cited by 2
The chemosensitizing effect of aqueous extract of sweet fennel on cisplatin treated HeLa cells
Ramadan, W. S., Sait, K., Anfinan, N. M., & Sait, H. (2016) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog2125.2016 · Cited by 2
4-Nerolidylcatechol induces autophagy in human glioblastoma cells
Massaro, R. R., Brohem, C. A., de Almeida, R. L., Rivelli, D. P., Miyake, J. A., Colquhoun, A., Barros, S. B. D. M., & Maria–Engler, S. S. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000300169 · Cited by 2
Molecular Pathways of Different Types of Cell Death: Many Roads to Death
Krysko, D. V., Kaczmarek, A., & Vandenabeele, P. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9293-0_1 · Cited by 2
Drug-Resistant Glioma: Treatment with Imatinib Mesylate and Chlorimipramine
Bılır, A., & Ergüven, M. (2011) · Springer eBooks · doi:10.1007/978-94-007-0344-5_26 · Cited by 1
Ciechomska, I. A., Ellert‐Miklaszewska, A., & Kaminska, B. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1431-5_5 · Cited by 1
Cinosi, V. (2011) · Oncology Reports · doi:10.3892/or.2011.1272 · Cited by 1
Targeting autophagy: do patents reveal a therapeutic potential?
Lefranc, F., Ingrassia, L., & Robert Kiss, A. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.8.813 · Cited by 1
Self-citationSchidandrin B kills tumor cells by initiating apoptosis in glioma SHG-44 cells
Qi, L., Yu, H., Li, Y., Jin, H. Y., Zhao, D., & Xu, Y. (2016) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-015-2406-9 · Cited by 1
Endoplasmic Reticulum Stress and Autophagy in Cancer
Tan, M., Tan, H. K., & Muhammad, T. S. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_18 · Cited by 1
Khanmiri, J. M., Mousavi, S. H., Alizadeh, S., & Khani-Eshratabadi, M. (2023) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.31.149.574 · Cited by 1
Genetic Signaling in Glioblastoma Multiforme (GBM): A Current Overview
Lukiw, W. J., & Culicchia, F. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_24 · Cited by 1
Enhancement of Cell Death in High-Grade Glioma Cells
Tiwari, M., Sharma, L. K., & Godbole, M. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-405530-8.00016-9 · Cited by 1
Nguyen, J., Chen, L., Kumar, D., & Lee, J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.08.035 · Cited by 1
Drug Combinations as a Therapeutic Approach for mTORC1 Inhibitors in Human Cancer
Breuleux, M., & Lane, H. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_8 · Cited by 1
de Sousa, J. F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-19072018-152637 · Cited by 1
Combining oncolytic immunotherapy with conventional cancer treatments
Liikanen, I. (2015) · Työväentutkimus Vuosikirja
The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview
Koropouli, E., Manolopoulos, L., Pandha, H., & Syrigos, K. (2009) · Current Enzyme Inhibition · doi:10.2174/157340809787314274
The Role of BNIP3 in Proliferation and Hypoxia-Induced Autophagy: Implications for Cancer Therapy
Azad, M. B. (2010) · Mspace (University of Manitoba)
Insights into the Molecular Role of Endocannabinoids in Diabetes Mellitus
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac121.470485
Retracted: Innovative Therapies against Human Glioblastoma Multiforme
Notices, I. S. R. (2019) · International Scholarly Research Notices · doi:10.1155/2019/8202879
RetractedStudy on the Sensitivity of Long Non-Coding RNA-HOTAIR to Radiotherapy for Malignant Tumors
肖, 雪. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.132335
Armstrong, J. L., Corazzari, M., Martin, S., Pagliarini, V., Falasca, L., Hill, D. S., Ellis, N., Sabah, S. A., Redfern, C. P. F., Fimia, G. M., et al. (2023) · doi:10.1158/1078-0432.c.6519183.v1
Etude des réponses induites par l’erlotinib dans des cellules de lignées de glioblastome
Eimer, S. (2011) · theses.fr (ABES) · doi:10.70675/48cf26bbz6b1cz4672za2d5zc83a7ce5752a
Saleh, A. M., Eldehna, W. M., Elnagar, M. R., Elmasry, G. F., Abdelrahman, M. A., El‐Zahabi, M. A., & Abou‐Seri, S. M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119401
BindingDB Entry 50043000: Therapeutic agents triggering nonapoptotic cancer cell death.
BindingDB (2014) · UC San Diego · doi:10.7270/q2d2200s
Autophagy and Necroptosis in Cancer
Tan, M., Tan, H. K., Moad, A. I. H., & Muhammad, T. S. T. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_14
Metadata
- Authors
- Lefranc, F., Facchini, V., & Kiss, R.
- Affiliations
- Université Libre de Bruxelles (BE)
- c Unibioscreen SA, Brussels, Belgium
- b Laboratory of Toxicology, Institute of Pharmacy, Université Libre de Bruxelles, Brussels, Belgium
- Corresponding author
- Lefranc, Florence
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-01
- Volume
- 12
- Issue
- 12
- Pages
- 1395-1403
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2099551830
- Cited by
- 237
- References
- 93
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 14 · 2016: 10 · 2015: 13 · 2014: 13 · 2013: 21 · 2012: 19
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- autophagic cell death, apoptosis resistance, glioblastoma, temozolomide, mTOR inhibitors, PI3K/Akt signaling, endoplasmic reticulum stress, combination chemotherapy, caspase-independent cell death
- MeSH terms
- Temozolomide, Antineoplastic Agents, Autophagy, Dacarbazine, Glioblastoma, Humans, Neoplasms, Drug Delivery Systems, Apoptosis, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review